SIRT2 and cardiac hypertrophy: The loss of SIRT2 inhibits the activation of AMPK, promotes ageing‐related and/or angiotensin II (Ang II)‐induced pathological cardiac hypertrophy and weakens the metformin‐mediated cardiac protection.